91 related articles for article (PubMed ID: 15705875)
1. Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice.
Zhou Z; Flesken-Nikitin A; Levine CG; Shmidt EN; Eng JP; Nikitina EY; Spencer DM; Nikitin AY
Cancer Res; 2005 Feb; 65(3):787-96. PubMed ID: 15705875
[TBL] [Abstract][Full Text] [Related]
2. Earlier onset of melanotroph carcinogenesis in mice with inherited mutant paternal allele of the retinoblastoma gene.
Nikitin AY; Riley DJ; Lee WH
Cancer Res; 1997 Oct; 57(19):4274-8. PubMed ID: 9331088
[TBL] [Abstract][Full Text] [Related]
3. Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice.
Nikitin AYu ; Lee WH
Genes Dev; 1996 Aug; 10(15):1870-9. PubMed ID: 8756345
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.
Hu N; Gutsmann A; Herbert DC; Bradley A; Lee WH; Lee EY
Oncogene; 1994 Apr; 9(4):1021-7. PubMed ID: 8134105
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tract.
Kucherlapati MH; Nguyen AA; Bronson RT; Kucherlapati RS
Cancer Res; 2006 Apr; 66(7):3576-83. PubMed ID: 16585182
[TBL] [Abstract][Full Text] [Related]
6. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA
Cancer Res; 1995 Mar; 55(5):1146-51. PubMed ID: 7867001
[TBL] [Abstract][Full Text] [Related]
7. Two distinct pituitary cell lines from mouse intermediate lobe tumors: a cell that produces prolactin-regulating factor and a melanotroph [seecomments].
Hnasko R; Khurana S; Shackleford N; Steinmetz R; Low MJ; Ben-Jonathan N
Endocrinology; 1997 Dec; 138(12):5589-96. PubMed ID: 9389547
[TBL] [Abstract][Full Text] [Related]
8. [Endocrine tumors in transgenic mice].
Fehmann HC; Göke B
Z Gastroenterol; 1996 Feb; 34(2):154-5. PubMed ID: 8659192
[No Abstract] [Full Text] [Related]
9. Effects of heterozygosity for the Rb-1t19neo allele in the mouse.
Harrison DJ; Hooper ML; Armstrong JF; Clarke AR
Oncogene; 1995 Apr; 10(8):1615-20. PubMed ID: 7731716
[TBL] [Abstract][Full Text] [Related]
10. A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis.
Leung SW; Wloga EH; Castro AF; Nguyen T; Bronson RT; Yamasaki L
Oncogene; 2004 Apr; 23(19):3296-307. PubMed ID: 15021915
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotroph tumors in Rb+/- mice.
Riley DJ; Nikitin AY; Lee WH
Nat Med; 1996 Dec; 2(12):1316-21. PubMed ID: 8946829
[TBL] [Abstract][Full Text] [Related]
12. RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice.
Nikitin AY; Juárez-Pérez MI; Li S; Huang L; Lee WH
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3916-21. PubMed ID: 10097138
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis.
Parisi T; Bronson RT; Lees JA
Oncogene; 2009 Jan; 28(4):500-8. PubMed ID: 18997819
[TBL] [Abstract][Full Text] [Related]
14. ARF mutation accelerates pituitary tumor development in Rb+/- mice.
Tsai KY; MacPherson D; Rubinson DA; Nikitin AY; Bronson R; Mercer KL; Crowley D; Jacks T
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16865-70. PubMed ID: 12486224
[TBL] [Abstract][Full Text] [Related]
15. Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia.
Matoso A; Zhou Z; Hayama R; Flesken-Nikitin A; Nikitin AY
Carcinogenesis; 2008 Mar; 29(3):620-8. PubMed ID: 17893233
[TBL] [Abstract][Full Text] [Related]
16. E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas.
Ziebold U; Lee EY; Bronson RT; Lees JA
Mol Cell Biol; 2003 Sep; 23(18):6542-52. PubMed ID: 12944480
[TBL] [Abstract][Full Text] [Related]
17. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
[TBL] [Abstract][Full Text] [Related]
19. Proopiomelanocortin heterozygous and homozygous null mutant mice develop pituitary adenomas.
Karpac J; Ostwald D; Li GY; Bui S; Hunnewell P; Brennan MB; Hochgeschwender U
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):47-52. PubMed ID: 16914086
[TBL] [Abstract][Full Text] [Related]
20. Extracellular-signal regulated kinase regulates production of pro-opiomelanocortin in pituitary melanotroph cells.
Kuribara M; Kidane AH; Vos GA; de Gouw D; Roubos EW; Scheenen WJ; Jenks BG
J Neuroendocrinol; 2011 Mar; 23(3):261-8. PubMed ID: 21129045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
